May 6 (Reuters) - Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration has ...
Since it was established nearly a year ago by the FDA, the Commissioner’s National Priority Voucher (CNPV) program has been ...
Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...
Morning Overview on MSN
FDA to fast-track reviews of 3 psychedelic drugs after Trump directive
The FDA will put three psychedelic drug programs on an ultra-fast approval track, compressing review timelines from roughly ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to as fast as two months, according to an Oct. 16 ...
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results